Alexion Pharmaceuticals, Inc.

Q3 2021 13F Holders

Symbol
ALXN
CUSIP
015351109
Type
Equity
Class
COM
Num filings
7
Total reported value, excl. options
$845 k
Manager Report Date Value ($000) Shares Option Type